Prognostic factors for CR + VGPR
| Variable . | Treatment-adjusted odds ratio . | ||
|---|---|---|---|
| Estimate . | 95% CI . | P . | |
| Chromosome 13 deletion | |||
| No | 1 | — | .068 |
| Yes | 1.73 | 0.96-3.11 | |
| β2-microglobulin, mg/L | |||
| ≤ 3 | 1 | — | .192 |
| ≥ 3 | 1.51 | 0.81-2.80 | |
| ≤ 3.5 | 1 | .912 | |
| ≥ 3.5 | 1.03 | 0.58-1.84 | |
| ≤ 6 | 1.87 | 0.85-4.12 | .116 |
| ≥ 6 | 1 | ||
| t(4;14) | |||
| No | 1 | — | .379 |
| Yes | 1.54 | 0.59-4.06 | |
| del17p | |||
| No | 1.74 | 0.57-5.30 | .328 |
| Yes | 1 | — | |
| t(4;14) or del 17p | |||
| No | 1 | — | .741 |
| Yes | 1.14 | 0.52-2.49 | |
| International Staging System | |||
| 1 | 1 | — | .323 |
| 2 | 1.18 | 0.61-2.30 | |
| 3 | 0.66 | 0.29-1.49 | |
| Performance status | |||
| 0 | 1 | — | .547 |
| 1 | 1.23 | 0.68-2.25 | |
| 2 | 1.69 | 0.42-6.81 | |
| 3 or 4 | 1.18 | 0.36-48.76 | |
| Mobilization with cyclophosphamide | |||
| No | 1.46 | 0.62-3.45 | .383 |
| Yes | 1 | — | |
| Variable . | Treatment-adjusted odds ratio . | ||
|---|---|---|---|
| Estimate . | 95% CI . | P . | |
| Chromosome 13 deletion | |||
| No | 1 | — | .068 |
| Yes | 1.73 | 0.96-3.11 | |
| β2-microglobulin, mg/L | |||
| ≤ 3 | 1 | — | .192 |
| ≥ 3 | 1.51 | 0.81-2.80 | |
| ≤ 3.5 | 1 | .912 | |
| ≥ 3.5 | 1.03 | 0.58-1.84 | |
| ≤ 6 | 1.87 | 0.85-4.12 | .116 |
| ≥ 6 | 1 | ||
| t(4;14) | |||
| No | 1 | — | .379 |
| Yes | 1.54 | 0.59-4.06 | |
| del17p | |||
| No | 1.74 | 0.57-5.30 | .328 |
| Yes | 1 | — | |
| t(4;14) or del 17p | |||
| No | 1 | — | .741 |
| Yes | 1.14 | 0.52-2.49 | |
| International Staging System | |||
| 1 | 1 | — | .323 |
| 2 | 1.18 | 0.61-2.30 | |
| 3 | 0.66 | 0.29-1.49 | |
| Performance status | |||
| 0 | 1 | — | .547 |
| 1 | 1.23 | 0.68-2.25 | |
| 2 | 1.69 | 0.42-6.81 | |
| 3 or 4 | 1.18 | 0.36-48.76 | |
| Mobilization with cyclophosphamide | |||
| No | 1.46 | 0.62-3.45 | .383 |
| Yes | 1 | — | |
— indicates not applicable.